Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
This study compares the effect of Ferrlecit® (a form of intravenous iron) to ferrous sulfate
(a form of oral iron) in treating anemia and iron deficiency in chronic kidney disease
patients who are not receiving erythropoietic agents (hormones that stimulate the bone marrow
to make more red blood cells).